Synthesis of Patient-Specific Transmission Data for PET Attenuation Correction for PET/MRI Neuroimaging Using a Convolutional Neural Network

Attenuation correction is a notable challenge associated with simultaneous PET/MRI, particularly in neuroimaging, where sharp boundaries between air and bone volumes exist. This challenge leads to concerns about the visual and, more specifically, quantitative accuracy of PET reconstructions for data obtained with PET/MRI. Recently developed techniques can synthesize attenuation maps using only MRI data and are likely adequate for clinical use; however, little work has been conducted to assess their suitability for the dynamic PET studies frequently used in research to derive physiologic information such as the binding potential of neuroreceptors in a region. At the same time, existing PET/MRI attenuation correction methods are predicated on synthesizing CT data, which is not ideal, as CT data are acquired with much lower-energy photons than PET data and thus do not optimally reflect the PET attenuation map. Methods: We trained a convolutional neural network to generate patient-specific transmission data from T1-weighted MRI. Using the trained network, we generated transmission data for a testing set comprising 11 subjects scanned with 11C-labeled N-[2-]4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide) (11C-WAY-100635) and 10 subjects scanned with 11C-labeled 3-amino-4-(2-dimethylaminomethyl-phenylsulfanyl)benzonitrile (11C-DASB). We assessed both static and dynamic reconstructions. For dynamic PET data, we report differences in both the nondisplaceable and the free binding potential for 11C-WAY-100635 and distribution volume for 11C-DASB. Results: The mean bias for generated transmission data was −1.06% ± 0.81%. Global biases in static PET uptake were −0.49% ± 1.7%, and −1.52% ± 0.73% for 11C-WAY-100635 and 11C-DASB, respectively. Conclusion: Our neural network approach is capable of synthesizing patient-specific transmission data with sufficient accuracy for both static and dynamic PET studies.

[1]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[2]  Rupert Lanzenberger,et al.  Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  H Zaidi,et al.  A novel energy mapping approach for CT-based attenuation correction in PET. , 2012, Medical physics.

[4]  Mattia Veronese,et al.  Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  G. Delso,et al.  Performance Measurements of the Siemens mMR Integrated Whole-Body PET/MR Scanner , 2011, The Journal of Nuclear Medicine.

[6]  Guy B. Williams,et al.  Attenuation Correction Methods Suitable for Brain Imaging with a PET/MRI Scanner: A Comparison of Tissue Atlas and Template Attenuation Map Approaches , 2011, The Journal of Nuclear Medicine.

[7]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[8]  Ciprian Catana,et al.  Toward Implementing an MRI-Based PET Attenuation-Correction Method for Neurologic Studies on the MR-PET Brain Prototype , 2010, The Journal of Nuclear Medicine.

[9]  Ciprian Catana,et al.  Transmission imaging for integrated PET-MR systems , 2016, Physics in medicine and biology.

[10]  Quanzheng Li,et al.  Attenuation correction for brain PET imaging using deep neural network based on Dixon and ZTE MR images , 2017, Physics in medicine and biology.

[11]  R. Wahl,et al.  PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  A. Buck,et al.  Clinical Evaluation of Zero-Echo-Time Attenuation Correction for Brain 18F-FDG PET/MRI: Comparison with Atlas Attenuation Correction , 2016, The Journal of Nuclear Medicine.

[13]  Adam Ciarleglio,et al.  Higher pretreatment 5‐HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: A naturalistic treatment pilot PET study , 2013, Synapse.

[14]  Martín Abadi,et al.  TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems , 2016, ArXiv.

[15]  Georges El Fakhri,et al.  Motion compensation for brain PET imaging using wireless MR active markers in simultaneous PET–MR: Phantom and non-human primate studies , 2014, NeuroImage.

[16]  R. Parsey,et al.  In vivo Quantification of Serotonin Transporters Using [11C]DASB and Positron Emission Tomography in Humans: Modeling Considerations , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Habib Zaidi,et al.  The Promise of Hybrid PET\/MRI: Technical advances and clinical applications , 2016, IEEE Signal Processing Magazine.

[18]  Ciprian Catana,et al.  PET/MRI for Neurologic Applications , 2012, The Journal of Nuclear Medicine.

[19]  Ninon Burgos,et al.  A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients , 2016, NeuroImage.

[20]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Pawel Markiewicz,et al.  PET Reconstruction With an Anatomical MRI Prior Using Parallel Level Sets , 2016, IEEE Transactions on Medical Imaging.

[22]  Gudrun Wagenknecht,et al.  MRI for attenuation correction in PET: methods and challenges , 2012, Magnetic Resonance Materials in Physics, Biology and Medicine.

[23]  A. McMillan,et al.  Deep learning Mr imaging–based attenuation correction for PeT/Mr imaging 1 , 2017 .

[24]  R Todd Ogden,et al.  Estimation of kinetic parameters in graphical analysis of PET imaging data , 2003, Statistics in medicine.

[25]  Andrew P. Leynes,et al.  Zero-Echo-Time and Dixon Deep Pseudo-CT (ZeDD CT): Direct Generation of Pseudo-CT Images for Pelvic PET/MRI Attenuation Correction Using Deep Convolutional Neural Networks with Multiparametric MRI , 2017, The Journal of Nuclear Medicine.

[26]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[27]  P A Sargent,et al.  Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11 C]WAY-100635. , 1996, European journal of pharmacology.

[28]  F. Wiesinger,et al.  Evaluation of Sinus/Edge-Corrected Zero-Echo-Time–Based Attenuation Correction in Brain PET/MRI , 2017, The Journal of Nuclear Medicine.

[29]  Xiao Han,et al.  MR‐based synthetic CT generation using a deep convolutional neural network method , 2017, Medical physics.

[30]  J. L. Herraiz,et al.  Fast Patch-Based Pseudo-CT Synthesis from T1-Weighted MR Images for PET/MR Attenuation Correction in Brain Studies , 2016, The Journal of Nuclear Medicine.

[31]  M. Kachelrieb,et al.  Improving PET/CT attenuation correction with iterative CT beam hardening correction , 2005, IEEE Nuclear Science Symposium Conference Record, 2005.

[32]  Georges El Fakhri,et al.  Accurate measurement of bone attenuation in PET-MR , 2015 .

[33]  T. Beyer,et al.  Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites , 2016, The Journal of Nuclear Medicine.

[34]  Christine DeLorenzo,et al.  Quantification of the Serotonin 1A Receptor Using PET: Identification of a Potential Biomarker of Major Depression in Males , 2015, Neuropsychopharmacology.

[35]  Christine DeLorenzo,et al.  In Vivo Quantification of Human Serotonin 1A Receptor Using 11C-CUMI-101, an Agonist PET Radiotracer , 2010, The Journal of Nuclear Medicine.

[36]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[37]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[38]  Mark Bydder,et al.  Qualitative and quantitative ultrashort echo time (UTE) imaging of cortical bone. , 2010, Journal of magnetic resonance.

[39]  Kevin T. Chen,et al.  An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging , 2014, The Journal of Nuclear Medicine.

[40]  Osama Mawlawi,et al.  Differential Occupancy of Somatodendritic and Postsynaptic 5HT1A Receptors by Pindolol: A Dose-Occupancy Study with [11C]WAY 100635 and Positron Emission Tomography in Humans , 2001, Neuropsychopharmacology.

[41]  N. Costes,et al.  Multi-atlas attenuation correction supports full quantification of static and dynamic brain PET data in PET-MR , 2017, Physics in medicine and biology.

[42]  Ramin V. Parsey,et al.  Acute Occupancy of Brain Serotonin Transporter by Sertraline as Measured by [11C]DASB and Positron Emission Tomography , 2006, Biological Psychiatry.